HistoIndex Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Private

  • Employees
  • 31

Employees

  • Latest Deal Type
  • Series A2

  • Latest Deal Amount
  • $6.78M

  • Investors
  • 8

HistoIndex General Information

Description

Developer of a digital pathology platform designed to improve the diagnosis of chronic liver conditions. The company's platform offers stain-free, multi-dimensional, quantitative imaging for visualizing and staging fibrosis, enabling medical professionals to accelerate precision diagnosis and therapeutic development.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Teletech Park
  • 20 Science Park Road, Number 01-26/27
  • Singapore, 117674
  • Singapore
+65 6774
Primary Industry
Decision/Risk Analysis
Other Industries
Other Healthcare Technology Systems
Corporate Office
  • Teletech Park
  • 20 Science Park Road, Number 01-26/27
  • Singapore, 117674
  • Singapore
+65 6774

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

HistoIndex Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series A2) 02-May-2025 $6.78M Completed Generating Revenue
4. Later Stage VC (Series A1) 06-Jun-2021 Completed Generating Revenue
3. Later Stage VC (Series A) 20-Sep-2016 Completed Generating Revenue
2. Grant $736K Completed Generating Revenue
1. University Spin-Out 01-Apr-2010 Completed Generating Revenue
To view HistoIndex’s complete valuation and funding history, request access »

HistoIndex Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A1
Series A
To view HistoIndex’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

HistoIndex Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a digital pathology platform designed to improve the diagnosis of chronic liver conditions. The company's p
Decision/Risk Analysis
Singapore, Singapore
31 As of 2026

Boston, MA
 

New Orleans, LA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

HistoIndex Competitors (3)

One of HistoIndex’s 3 competitors is Biofourmis, a Formerly VC-backed company based in Boston, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Biofourmis Formerly VC-backed Boston, MA
Fibronostics Venture Capital-Backed New Orleans, LA
Aiforia Technologies Formerly VC-backed Helsinki, Finland
You’re viewing 3 of 3 competitors. Get the full list »

HistoIndex Patents

HistoIndex Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202408636-D0 Method and system for predicting a clinical outcome of metabolic dysfunction-associated steatotic liver disease Active 21-Jun-2023
GB-2631590-A Method and system for predicting a clinical outcome of metabolic dysfunction-associated steatotic liver disease Active 21-Jun-2023
GB-2631590-B Method and system for predicting a clinical outcome of metabolic dysfunction-associated steatotic liver disease Active 21-Jun-2023
US-20240428947-A1 Method and system for predicting a clinical outcome of metabolic dysfunction-associated steatotic liver disease Pending 21-Jun-2023
WO-2023249562-A1 Method and system for evaluating change in liver fibrosis Inactive 22-Jun-2022 G16H50/20
To view HistoIndex’s complete patent history, request access »

HistoIndex Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

HistoIndex Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Oversea-Chinese Banking Corporation Corporation Minority
Angel (individual) Minority
SEEDS Capital Corporate Venture Capital Minority
Angel (individual) Minority
SNS HOLDINGS PTE. LTD. Corporation Minority
You’re viewing 5 of 8 investors. Get the full list »

HistoIndex FAQs

  • When was HistoIndex founded?

    HistoIndex was founded in 2010.

  • Where is HistoIndex headquartered?

    HistoIndex is headquartered in Singapore, Singapore.

  • What is the size of HistoIndex?

    HistoIndex has 31 total employees.

  • What industry is HistoIndex in?

    HistoIndex’s primary industry is Decision/Risk Analysis.

  • Is HistoIndex a private or public company?

    HistoIndex is a Private company.

  • What is HistoIndex’s current revenue?

    The current revenue for HistoIndex is .

  • How much funding has HistoIndex raised over time?

    HistoIndex has raised $12.3M.

  • Who are HistoIndex’s investors?

    Oversea-Chinese Banking Corporation, , SEEDS Capital, , and SNS HOLDINGS PTE. LTD. are 5 of 8 investors who have invested in HistoIndex.

  • Who are HistoIndex’s competitors?

    Biofourmis, Fibronostics, and Aiforia Technologies are competitors of HistoIndex.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process